This report describes the global market size of Neuroelectronic Devices from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 10.2% from 2024 to 2031.
Due to the COVID-19 pandemic, the global market for Neuroelectronic Devices estimated at US 6.2 $ billion in the year 2023, is projected to reach a revised size of US 111.718 $ million by 2031, growing at a CAGR of 10.2% during the forecast period 2024-2031.
Neuroelectronic Devices refers to the use of virtual reality technology to alleviate pain and aid in the rehabilitation process. By immersing patients in virtual environments and providing interactive experiences, VR therapy can distract from pain sensations, facilitate physical and cognitive exercises, and promote healing and recovery in various medical conditions and injuries.
For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Neuroelectronic Devices as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Device Type:
Implantable Neuroelectronic Devices
Non-Implantable Neuroelectronic Devices
In 2023,In the neuroelectronic devices market, "Implantable Neuroelectronic Devices" are surgically inserted into the body to directly interface with neural tissue, used for applications such as deep brain stimulation and cochlear implants. "Non-Implantable Neuroelectronic Devices" are external devices that interact with the nervous system without requiring surgery, including transcutaneous electrical nerve stimulation (TENS) and electroencephalography (EEG) systems.
By Application:
Neurological Disorders
Sensory Disorders
Cognitive Enhancement
Research and Diagnostics
In 2023,In the neuroelectronic devices market, "Neurological Disorders" applications involve devices used to treat conditions like Parkinson's disease and epilepsy through neuromodulation techniques. "Sensory Disorders" applications include devices that restore or enhance sensory functions such as hearing aids and retinal implants. "Cognitive Enhancement" devices aim to improve cognitive abilities through brain stimulation techniques. "Research and Diagnostics" devices are used in neuroscience research and clinical diagnostics, providing insights into brain activity and disorders through techniques like EEG and fMRI.
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Research Institutions
Home Care Settings
In the neuroelectronic devices market, "Hospitals and Clinics" are primary users where devices are utilized for diagnosis and treatment of neurological conditions, offering comprehensive medical care. "Ambulatory Surgical Centers" deploy these devices for minimally invasive procedures, providing convenient outpatient care with reduced recovery times. "Research Institutions" employ neuroelectronic devices for pioneering studies and advancements in neuroscience, fostering innovation in treatments and diagnostics. "Home Care Settings" increasingly incorporate these devices to empower patients with neurological disorders to manage their conditions independently, enhancing quality of life through remote monitoring and therapy.
By End-User
Hospitals and Clinics
Rehabilitation Centers
Home Care Settings
Research and Academic Institutions
In the neuroelectronic devices market, "Hospitals and Clinics" utilize these devices for diagnosing and treating neurological disorders such as Parkinson's disease and chronic pain management, ensuring comprehensive medical care. "Rehabilitation Centers" employ neuroelectronic devices for aiding recovery from neurological injuries or conditions, facilitating physical and cognitive rehabilitation through targeted stimulation techniques. "Home Care Settings" increasingly integrate these devices to provide patients with ongoing neurological care and monitoring in the comfort of their homes, promoting independence and quality of life. "Research and Academic Institutions" leverage neuroelectronic devices for advancing neuroscience research, developing new therapies, and training future healthcare professionals in innovative treatment modalities.
Company-
Medtronic
Boston Scientific Corporation
Abbott Laboratories
LivaNova PLC
Cochlear Limited
NeuroPace, Inc.
Natus Medical Incorporated
Nevro Corp.
Aleva Neurotherapeutics SA
Brainsway Ltd.
Please ask for sample pages for full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
Global Surgical Equipment Market
Global Interventional Oncology Market
Global Brain-Computer Interface (BCI) Market
Europe Hormone Replacement Therapy Market
Global Medical Tubing Market
Global Gene Silencing Market
Europe Veterinary 3D Printing Market
Global Beauty Supplements Market
Global Human Organoid Market
Global Assisted Reproductive Technology Market
Your phrase has been sent to nick's email. Once he takes action. you will be notified!
Stats And Research ™ Copyright © 2025 .
